Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ACP Energy plc Board/Management Information 2020

Jun 12, 2020

5095_mang_2020-06-12_49224273-db73-492a-8007-39da308c389c.html

Board/Management Information

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 7023P

Advance Energy PLC

12 June 2020

12 June 2020

Advance Energy plc

("Advance" or the "Company")

Appointment of Buchanan as Communications & IR Adviser

Advance Energy plc (AIM: ADV), the upstream oil and gas company focussed on building a portfolio of value accretive non-operated interests in established hydrocarbon projects, is pleased to announce the appointment of Buchanan (https://buchanan.uk.com/) as its communications and IR adviser with immediate effect. 

The Company has appointed Buchanan to provide effective communications services to support its ambitious growth objectives. 

Following the appointment of Buchanan, all shareholder queries should be directed to [email protected].

For further information, please contact:

Advance Energy plc

Leslie Peterkin (CEO) / Stephen West (CFO)              +44 (0)1624 681 250

Buchanan (Public Relations)

Ben Romney / Kelsey Traynor                                      +44 (0)20 7466 5000

Beaumont Cornish Limited (Nominated Adviser)

Roland Cornish / James Biddle                                    +44 (0) 20 7628 3396

Novum Securities Limited (Joint Broker)

Colin Rowbury                                                                 +44 (0)20 7399 9427

Optiva Securities Limited (Joint Broker)

Christian Dennis                                                               +44 (0)20 3411 1881

For further information, please visit www.advanceplc.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

NRAMZGMVMMMGGZM